Blox (BLXX) 10-Q 14 Feb 20 2020 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Dec. 31, 2019	Feb. 14, 2020
Document and Entity Information
Entity Registrant Name	Blox, Inc.
Entity Central Index Key	0001428389
Amendment Flag	false
Current Fiscal Year End Date	--03-31
Document Type	10-Q
Document Period End Date	Dec. 31, 2019
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2020
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		143,172,664
Entity File Number	333-150582
Entity Interactive Data Current	Yes
Entity Incorporation State Country Code	NV

Condensed Interim Consolidated

Condensed Interim Consolidated Balance Sheets (Unaudited) - USD ($)	Dec. 31, 2019	Mar. 31, 2019
Current Assets
Cash (Note 8)	$ 46,206	$ 9,792
Prepaid expenses	11,167	5,167
Total Current Assets	57,373	14,959
Long term investments (Note 4)	68,731	122,295
Equipment (Note 5)	71,560	71,560
Mineral Property Interest (Note 6)	931,722	931,722
Total Assets	1,129,386	1,140,536
Current Liabilities
Accounts payable and accrued liabilities	275,558	229,008
Due to shareholder (Note 9)	390,164	329,346
Convertible debenture (Note 10)	96,606
Loan interest payable (Note 10)	2,516
Total Liabilities	764,844	558,354
STOCKHOLDERS' EQUITY
Common Stock (Note 7) - 400,000,000 authorized - 143,172,664 issued (March 31, 2019 - 142,822,664)	1,311	1,309
Additional Paid-in Capital	7,354,934	7,337,352
Contributed Surplus	15,754,290	15,658,030
Accumulated Other Comprehensive Income	24,465	55,019
Deficit	(22,770,458)	(22,469,528)
Total Stockholders' Equity	364,542	582,182
Total Liabilities and Stockholders' Equity	$ 1,129,386	$ 1,140,536

Condensed Interim Consolidate_2

Condensed Interim Consolidated Balance Sheets (Unaudited) (Parenthetical) - shares	Dec. 31, 2019	Mar. 31, 2019
Statement of Financial Position [Abstract]
Common stock, shares authorized	400,000,000	400,000,000
Common stock, shares issued	143,172,664	142,822,664

Condensed Interim Consolidate_3

Condensed Interim Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Operating Expenses
Consulting and professional fees (Note 12)	$ 37,385	$ 44,148	$ 114,887	$ 156,964
Exploration (Note 6)	12,061	88,917	47,574	118,004
Foreign exchange	2,936	(1,805)	5,677	1,061
Office and administration fees	2,796	7,609	24,316	28,110
Travel		1,186		10,125
Total Operating Expenses	(55,178)	(140,055)	(192,454)	(314,264)
Other Income (Loss)
Interest (expenses) income	(1,890)		(2,516)	47
Unrealized loss on investment in warrants (Note 4)	(2,156)	(61,050)	(23,010)	(10,410)
Accretion (Note 10)	(56,162)		(72,950)
Debt issuance cost - cash (Note 10)			(10,000)
Net Loss for the Period	(115,386)	(201,105)	(300,930)	(324,627)
Other Comprehensive Income
Unrealized gain (loss) on investment in common shares (Note 4)	1,283	(70,373)	(30,554)	(14,527)
Comprehensive Loss for the Period	$ (114,103)	$ (271,478)	$ (331,484)	$ (339,154)
Net Loss Per Common Share	$ 0	$ 0	$ 0	$ 0
Weighted Average Number of Shares Outstanding - Basic and diluted	143,172,664	142,366,414	142,999,573	139,214,959

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Common Stock	Additional Paid-in Capital	Share Subscriptions Received	Contributed Surplus	Accumulated Other Comprehensive Income	Deficit	Total
Balance at Mar. 31, 2018	$ 967	$ 5,957,211	$ 1,469,516	$ 4,379,700	$ 35,794	$ (10,854,427)	$ 988,761
Balance, shares at Mar. 31, 2018	108,611,814
Private placement (Notes 7(a)&7(b))	$ 300	752,700	(1,469,516)	747,000			30,484
Private placement (Notes 7(a)&7(b)), shares	30,000,000
Stock options exercised (Note 7(c))	$ 38	593,225		(593,263)
Stock options exercised (Note 7(c)), shares	3,754,600
Unrealized gain on investment in common shares (Note 4)					(14,527)		(14,527)
Net loss for the period						(324,627)	(324,627)
Balance at Dec. 31, 2018	$ 1,305	7,303,136		4,533,437	21,267	(11,179,054)	680,091
Balance, shares at Dec. 31, 2018	142,366,414
Balance at Mar. 31, 2019	$ 1,309	7,337,352		15,658,030	55,019	(22,469,528)	582,182
Balance, shares at Mar. 31, 2019	142,822,664
Unrealized gain on investment in common shares (Note 4)					(30,554)		(30,554)
Commitment shares issued (Note 10)	$ 1	13,838					13,839
Commitment shares issued (Note 10), shares	300,000
Warrants exercised (Note 7)	$ 1	$ 3,744		$ (1,245)			$ 2,500
Warrants exercised (Note 7), shares	50,000
Warrants issued (Note 10), shares				50,867			50,867
Convertible debenture - equity portion (Note 10)				$ 46,638			$ 46,638
Net loss for the period						(300,930)	(300,930)
Balance at Dec. 31, 2019	$ 1,311	$ 7,354,934		$ 15,754,290	$ 24,465	$ (22,770,458)	$ 364,542
Balance, shares at Dec. 31, 2019	143,172,664

Condensed Interim Consolidate_4

Condensed Interim Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
CASH PROVIDED BY (USED IN): OPERATING ACTIVITIES
Net loss for the period	$ (300,930)	$ (324,627)
Non-cash items:
Unrealized loss on investment in warrants	23,010	10,410
Accretion	72,950
Changes in non-cash working capital:
Prepaid expenses	(6,000)	(4,000)
Accounts payable and accrued liabilities	46,550	68,139
Loan interest payable	2,515
Due to shareholder	60,819	223,145
Cash used in operating activities	(101,086)	(26,933)
INVESTING ACTIVITIES
Purchase of long-term investments		(23,850)
FINANCING ACTIVITIES
Proceeds from private placement		30,484
Warrants exercised	2,500
Proceeds from convertible debenture	150,000
Convertible debt transaction costs	(15,000)
Cash used in financing activities	137,500	30,484
Increase (Decrease) in Cash	36,414	(20,299)
Cash, Beginning of Period	9,792	28,481
Cash, End of Period	46,206	8,182
Non-Cash Transactions:
Cashless stock options exercised		$ 593,263

Description of Business

Description of Business	9 Months Ended
	Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business	1. Description of Business Blox, Inc. (the "Company") was incorporated on July 21, 2005 under the laws of the state of Nevada. The address of the Company is #1177 Avenue of Americas 5th Floor, New York, NY 10036. The Company is primarily engaged in developing mineral exploration projects in Guinea, West Africa.

Basis of Presentation

Basis of Presentation	9 Months Ended
	Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	2. Basis of Presentation (a) Statement of Compliance These condensed interim consolidated financial statements are presented in accordance with generally accepted accounting principles in the United States ("US GAAP") and the rules and regulations of the Securities and Exchange Commission ("SEC") and are expressed in U.S. dollars. The Company's fiscal year-end is March 31. (b) Basis of Presentation The condensed interim consolidated financial statements of the Company comprise the Company and its subsidiaries. These condensed interim consolidated financial statements are prepared on the historical cost basis. These condensed interim consolidated interim financial statements have also been prepared using the accrual basis of accounting, except for cash flow information. In the opinion of management, all adjustments (including normal recurring ones), considered necessary for the fair statement of results have been included in these financial statements. All intercompany balances and transactions have been eliminated upon consolidation. The interim results are not necessarily indicative of results for the full year ending March 31, 2020, or future operating periods. For further information, see the Company's annual consolidated financial statements for the year ended March 31, 2019, including the accounting policies and notes thereto. (c) Reporting and Functional Currencies The functional currency of an entity is the currency of the primary economic environment in which the entity operates. The functional currency of the Company is the Canadian dollar ("CAD"). The Company's reporting currency is the US dollar. Transactions: Monetary assets and liabilities denominated in foreign currencies are translated into functional currencies of the Company and its subsidiaries using period end foreign currency exchange rates and expenses are translated using the exchange rate approximating those in effect on the date of the transactions during the reporting periods in which the expenses were transacted. Non-monetary assets and liabilities are translated at their historical foreign currency exchange rates. Gains and losses resulting from foreign exchange transactions are included in the determination of net income or loss for the period. Translations: Foreign currency financial statements are translated into the Company's reporting currency, the US dollar as follows: (i) All of the assets and liabilities are translated at the rate of exchange in effect on the balance sheet date; (ii) Expenses are translated at the exchange rate approximating those in effect on the date of the transactions; and (iii) Exchange gains and losses arising from translation are included in other comprehensive income. (d) Significant Accounting Judgments and Estimates The preparation of these consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of expenses during the period. Actual outcomes could differ from these estimates. Revisions to accounting estimates are recognized in the period in which the estimate is revised and may affect both the period of revision and future periods. In applying the Company's accounting policies, management has made certain judgments that may have a significant effect on the consolidated financial statements. Such judgments include the determination of the functional currencies and use of the going concern assumption. (i) Determination of Functional Currencies In determining the Company's functional currency, it periodically reviews its primary and secondary indicators to assess the primary economic environment in which the entity operates in determining the Company's functional currencies. The Company analyzes the currency that mainly influences labor, material and other costs of providing goods or services which is often the currency in which such costs are denominated and settled. The Company also analyzes secondary indicators such as the currency in which funds from financing activities such as equity issuances are generated and the funding dependency of the parent company whose predominant transactional currency is the Canadian dollar. Determining the Company's predominant economic environment requires significant judgment. (ii) Going Concern These condensed interim consolidated financial statements have been prepared on a going concern basis, which implies the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The Company has incurred a net loss of $300,930 for the nine months ended December 31, 2019 and has incurred cumulative losses since inception of $22,770,458 as at December 31, 2019. These factors raise substantial doubt about the ability of the Company to continue as going concern. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, the ability of the Company to obtain necessary debt and/or equity financing to continue operations. These condensed interim consolidated financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. Management of the Company has undertaken steps as part of a plan to sustain operations for the next fiscal year including plans to raise additional equity financing, controlling costs and reducing operating losses.

Recent Accounting Pronouncement

Recent Accounting Pronouncements	9 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Recent Accounting Pronouncements	3. Recent Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

Long Term Investments

Long Term Investments	9 Months Ended
	Dec. 31, 2019
Long-term Investments [Abstract]
Long Term Investments	4. Long Term Investments Fair Value as at Number December 31, 2019 March 31, FVTPL Share purchase warrants 3,333,333 $ 1,416 $ 19,046 1,000,000 590 5,970 2,006 25,016 Available-for-sale Common shares 3,333,333 51,327 74,830 1,000,000 15,398 22,449 66,725 97,279 Total investment: $ 68,731 $ 122,295 On April 16, 2018, the Company participated in a private placement offering by its strategic partner, Ashanti Sankofa Inc (TSX.V- ASI), which shares the same management group and board of directors as the Company. The Company purchased 1,000,000 units at CAD$0.03 per unit for a total cost of $23,850 (CAD$30,000). Each unit consists of one common share and one transferable share purchase warrant with each warrant entitling the holder to acquire one additional common share at a price of CAD$0.05 for a period of 24 months from the closing of the private placement. On the date of issuance, the Company determined the fair value of the common share and warrants to be $13,420 and $10,430, respectively. As at December 31, 2019, the fair value of common shares was $66,725 which resulted in an unrealized loss of $30,554 that was recorded in other comprehensive income. In addition, the fair value of warrants was $2,006, which resulted in a loss of $23,010 that was recorded in net income. The December 31, 2019 fair value of the warrants was determined with the Black-Scholes option pricing model using the following assumptions: risk free interest rate of 1.67%, volatility of 86.01% – 88.73%, annual rate of dividend of 0%, and expected life of 0.25 years.

Equipment

Equipment	9 Months Ended
	Dec. 31, 2019
Property, Plant and Equipment [Abstract]
Equipment	5 . Equipment Machinery Total Cost Balance at December 31 & March 31, 2019 $ 232,620 $ 232,620 Accumulated Depreciation Balance at December 31 & March 31, 2019 $ 161,060 $ 161,060 Carrying amounts As at December 31 & March 31, 2019 $ 71,560 $ 71,560 Machinery in the amount of $71,560 has not been placed into production and is not currently being depreciated.

Mineral Property Interest

Mineral Property Interest	9 Months Ended
	Dec. 31, 2019
Mineral Property Interest [Abstract]
Mineral Property Interest	6 . Mineral Property Interest The Company entered into a Deed of Assignment and Assumption Agreement dated July 24, 2014 (the "Assumption Agreement") among Joseph Boampong Memorial Institute Ltd. ("JBMIL") and Equus Mining Ltd. ("EML"), Burey Gold Guinee sarl ("BGGs") and Burey Gold Limited ("BGL") and, collectively with EML and BGGs, (the "Vendors"), pursuant to which the Company agreed to assume JBMIL's right to acquire a 78% beneficial interest in the Mansounia Concession (the "Property") from the Vendors. The Company exercised that right and acquired a 78% beneficial interest in the Property. The Property lies in the southwest margin of the Siguiri Basin, in the Kouroussa Prefecture, Kankan Region, in Guinea, West Africa and covers a surface area of 145 square kilometres. The Property is located approximately 80 kilometres west, by road, from the country's third largest city, Kankan. In consideration for the acquisition of the interest in the Property, the Company paid in cash $100,000 to BGL and $40,000 to EML and issued BGL and EML an aggregate of 6,514,350 shares of common stock of the Company (the "First Tranche Shares"), at a deemed price of $0.1765 per share, for an aggregate deemed value of $1,150,000. The First Tranche Shares were issued to BGL and EML in the proportions of 71.43% and 28.57%, respectively. For accounting purposes, the Company recorded the cash payment of $140,000, and $10,000 for an independent valuation of the Property. Additionally, $781,722 was capitalized to mineral property interests, being the fair value of the first tranche of shares. The fair value of the first tranche shares was based on the closing price of the Company's shares on the OTCQB on July 24, 2014. Within 14 days of commercial gold production being publicly declared from ore mined from the Property, the Company will issue BGL and EML a second tranche of shares of common stock of the Company (the "Second Tranche Shares"). The number of Second Tranche Shares to be issued shall be calculated by dividing $1,150,000 by the volume weighted average share price of the Company's common stock over a 20-day period preceding the issuance date. The Second Tranche Shares shall be issued to BGL and EML in the proportions of 71.43% and 28.57%, respectively. The Company submitted an application to Ministrere des Mines for mining permit on December 7, 2018. The mining exploration permit for the Company expired on April 30, 2019. On June 27, 2019, Ministrere des Mines sent a letter to the Company to extend the mining exploration license for six months. In July, the mining exploration license for the Company was renewed. On November 11, 2019, the Company submitted a mining permit application. On December 27, 2019, the company submitted evidence of existence of available financing to Ministrere des Mines, On January 6, 2020, Ministrere des Mines sent a letter to the company to request for more evidence of availability of funding in order to obtain the mining permit. Mansounia Property, West Africa Acquisition of mineral property interest Cash payment $ 150,000 Issuance of 6,514,350 common shares 781,722 Balance, December 31 & March 31, 2019 $ 931,722 During the nine months ended December 31, 2019, the Company spent $47,574 (2018 – $118,004) on the property.

Common Stock

Common Stock	9 Months Ended
	Dec. 31, 2019
Equity [Abstract]
Common Stock	7 . Common Stock (a) Private Placement Year ended March 31, 2019 On September 29, 2017, the Company entered into an agreement with Waratah Capital Ltd. ("Waratah"), a controlling shareholder, whereby Waratah and the Company agreed that in order to allow the Company to finalize its acquisition of Quivira Gold Ltd. pursuant to the Share Purchase Agreement dated June 22, 2013 among the Company, Quivira Gold Ltd. and Waratah (the "Quivira Agreement"), the Bridge Loan Agreement dated as of April 17, 2015, and amended on April 28, 2016 and November 1, 2016 between the Company and Waratah would be cancelled and the Company will utilize the loan proceeds advanced to close a private placement of $1,500,000 required to consummate the Company's acquisition of Quivira Gold Ltd. On April 24, 2018, the Company closed the private placement as part of the Quivira acquisition and issued 30,000,000 units at a price of $0.05 per unit for gross proceeds of $1,500,000. Each unit consists of one common share and one transferable share purchase warrant exercisable at a price of $0.05 per share for a term of five years. Nine months ended December 31, 2019 There were no shares issued from private placement for the nine months ended December 31, 2019. (b) Commitment (restricted) shares issuance On August 16, 2019, the Company issued 300,000 committee shares to two convertible debenture holders. The fair value of the common shares was $60,000 (Note 10). (c) Warrants Year ended March 31, 2019 On April 24, 2018, the Company issued 30,000,000 share purchase warrants as part of the $1,500,000 private placement. The warrants expire five years from the date of issuance and are exercisable at $0.05 per share. The fair value of these warrants was determined with the Black-Scholes option pricing model using the following assumptions: risk free interest rate of 2.73%, volatility of 204.3%, annual rate of dividend of 0%, and expected life of 5 years. Nine months ended December 31, 2019 50,000 warrants were exercised for common shares during the nine months ended December 31, 2019. On August 16, 2019, the Company issued 1,111,110, warrants to two convertible debenture holders with a fair value of $220,541 (Note 10). On the issuance date of the warrants, the share price was $0.20. The warrants expire five years from the date of issuance and are exercisable at $0.135 per share. The fair value of these warrants was determined with the Black-Scholes option pricing model using the following assumptions: risk free interest rate of 1.57%, volatility of 231.6%, annual rate of dividend of 0%, and expected life of 5 years. The following table summarizes historical information about the Company's warrants: Number of Warrants Weighted Average Exercise Price ($) Weighted Average Life Remaining (Years) Balance, March 31, 2019 117,543,750 0.05 0.98 Warrants issued 1,111,110 0.135 4.6 Warrants exercised (50,000 ) 0.05 Balance, December 31, 2019 118,604,860 0.05 1.02 As at December 31, 2019, the following warrants were outstanding and exercisable: Number of Warrants Exercise Price Expiry Date 87,543,750 $ 0.05 February 27, 2020 29,950,000 $ 0.05 April 24, 2023 1,111,110 $ 0.135 August 16, 2024 118,604,860 (d) Stock Options Year ended March 31, 2019 On June 26, 2018, 4,000,000 stock options were exercised via cashless exercise at a price of $0.01 per share, resulting in issuance of 3,754,600 common shares. The cash component, equivalent to $40,000, is calculated as 245,400 shares at $0.163, the closing market price of the Company on the date of issuance. Nine months ended December 31, 2019 650,000 options expired on August 7, 2019. There were no stock options granted for the nine months ended December 31, 2019. The following table summarizes historical information about the Company's incentive stock options: Number of options Weighted Average Exercise Price ($) Weighted Average Life Remaining (Years) Balance, March 31, 2019 2,150,000 0.23 2.80 Expired (650,000 ) 0.15 Balance, December 31, 2019 1,500,000 0.27 3.10 At December 31, 2019, the following stock options were outstanding and exercisable: Number of Options Exercise Price Weighted Average Remaining Life in Years Expiry Date 1,500,000 $ 0.27 3.1 February 15, 2023

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
	Dec. 31, 2019
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	8. Fair Value of Financial Instruments The following provides an analysis of financial instruments that are measured subsequent to initial recognition at fair value, grouped into Levels 1 to 3 based on the degree to which fair value is observable: Level 1 – fair value measurements are those derived from quoted prices (unadjusted) in active markets for identical assets or liabilities; Level 2 – fair value measurements are those derived from inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices); and Level 3 – fair value measurements are those derived from valuation techniques that include inputs for the asset or liability that are not based on observable market data (unobservable inputs). Level 2 and 3 financial instruments are measured using management's best estimate of fair value, where the inputs into the determination of fair value require significant management judgment to estimation. Valuations based on unobservable inputs are highly subjective and require significant judgments. Changes in such judgments could have a material impact on fair value estimates. In addition, since estimates are as of a specific point in time, they are susceptible to material near-term changes. Changes in economic conditions may also dramatically affect the estimated fair values. The following table sets forth the Company's financial assets measured at fair value by level within the fair value hierarchy: Level 1 Level 2 Level 3 Total Cash $ 46,206 $ - $ - $ 46,206 Long-term investment – Shares 66,725 - - 66,725 Long-term investment – Warrants - - 2,006 2,006 Total $ 112,931 $ - $ 2,006 $ 114,937 Level 1 Level 2 Level 3 Total Cash $ 9,792 $ - $ - $ 9,792 Long-term investment – Shares 97,279 - - 97,279 Long-term investment – Warrants - - 25,016 25,016 Total $ 107,071 $ - $ 25,016 $ 132,087

Due to Shareholder

Due to Shareholder	9 Months Ended
	Dec. 31, 2019
Related Party Transactions [Abstract]
Due to Shareholder	9. Due to Shareholder During the nine months ended December 31, 2019, the Company received advances from Waratah Capital Ltd. ("Waratah"), a controlling shareholder of the Company, in the amount of $60,820. As at December 31, 2019, the Company was indebted to Waratah for $390,164 (March 31, 2019 - $329,346). The advances from shareholder are unsecured, non-interest bearing and have no fixed repayment terms.

Convertible Debenture

Convertible Debenture	9 Months Ended
	Dec. 31, 2019
Convertible Debenture
Convertible Debenture	10. Convertible Debenture On August 16, 2019, the Company entered into security purchase agreements with two private investors, issuing two convertible promissory notes in an aggregate principal amount of $150,000, with a $15,000 original issue discount and $10,000 in legal fees, paid in cash to the investors and the legal counsel. Each note accrues interest at an annual rate of 5% and is to be repaid nine months after the dates of actual funding received. The investors have rights to convert a portion, or all, of the principal amount plus interest of each note at a lowest conversion price of i) $0.09 (fixed conversion price); or ii) 50% multiplied by the lowest closing bid price of the Common Stock during the 25 consecutive trading day period immediately preceding the date of the respective conversion (alternative conversion price) into common shares of the Company after 180 days and prior to May 16, 2020. In addition, the Company issued 300,000 commitment shares to the two investors with a fair value of $60,000 and 1,111,110 warrants with a fair value of $220,541. The two warrant holders are entitled to purchase up to 1,111,110 common shares of the Company at an exercise price of $0.135 with a 5-year expiry date (Note 7 (b) & (c)) Based on a discount factor of 66%, the debt portion of the promissory note was valued at $102,567 and the conversion feature portion of the notes was valued at $202,208. The conversion feature was valued using the Black Scholes model with the following assumptions: risk free interest rate of 1.61%, volatility of 100.01%, dividend rate of 0% and expected life of 9 months. The net proceeds received by the Company were allocated to the convertible debt and associated financial instruments based on their relative fair values as below: Proceeds Allocation Debt $ 23,656 Conversion feature 46,638 Warrants 50,867 Shares 13,839 Total proceeds $ 135,000 For the nine months ended December 31, 2019, accretion for the notes was calculated as $72,950 (2018 - $Nil) and interest expense of $2,516 was recorded. As at December 31, 2019, the carrying value of the convertible notes is as below: December 31, 2019 Convertible debenture – beginning of the period $ - Debt proceeds received 23,656 Finance cost - accretion 72,950 Carrying value – end of the period $ 96,606

Commitments

Commitments	9 Months Ended
	Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Commitments	11. Commitments On June 22, 2013, the Company entered into a share purchase agreement with Waratah Capital Ltd. ("Waratah") where the Company agreed to purchase all of Waratah's right, title, and interest in the Quivira Gold ("Quivira") shares, of which Waratah holds 100% of the outstanding shares. As consideration for the Quivira shares, the Company will issue to Waratah 60,000,000 shares of common stock and 60,000,000 warrants. Each warrant entitles the holder to purchase one additional common share at $0.05 for a period of five years from the closing date. Quivira, a subsidiary of Waratah Investments, owns and operates gold and diamond mining properties in Ghana. The closing of the agreement is subject to the completion of due diligence and the completion of a private placement for $1,500,000. The private placement closed during the year ended March 31, 2019. As of the issuance date of these financial statements, the due diligence has not yet been completed.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Dec. 31, 2019
Related Party Transactions [Abstract]
Related Party Transactions	12. Related Party Transactions The Company's related parties include its subsidiaries, key management personnel, controlling shareholders, and strategic partner. Transactions with related parties for goods and services are based on the exchange amount as agreed to by the related parties. The Company incurred the following expenses with related parties during the nine months ended December 31, 2019 and 2018: Nine Months Ended 2019 2018 Compensation – CEO $ 40,500 $ 20,705 Compensation – Former CEO - 47,660 Compensation – CFO 21,591 21,805 Compensation – Former Officer - 12,262 $ 62,091 $ 102,432 As at December 31, 2019, the Company was indebted to its related parties for the amounts as below: December 31, March 31, Accounts payable and accrued liabilities $ 119,476 $ 93,104 Due to shareholder (Note 9) 390,164 329,346 These amounts owing are unsecured, non-interest bearing and have no fixed repayment terms.

Geographical Area Information

Geographical Area Information	9 Months Ended
	Dec. 31, 2019
Segments, Geographical Areas [Abstract]
Geographical Area Information	13 . Geographical Area Information Canada Africa Total December 31, 2019: Current assets $ 56,071 $ 1,302 $ 57,373 Long term investments 68,731 - 68,731 Equipment - 71,560 71,560 Mineral property interest - 931,722 931,722 Total assets $ 124,802 $ 1,004,584 $ 1,129,386 Total liabilities $ 669,899 $ 94,945 $ 764,844 March 31, 2019: Current assets $ 13,367 $ 1,592 $ 14,959 Long term investments 122,295 - 122,295 Equipment - 71,560 71,560 Mineral property interest - 931,722 931,722 Total assets $ 135,662 $ 1,004,874 $ 1,140,536 Total liabilities $ 509,401 $ 48,953 $ 558,354

Long Term Investments (Tables)

Long Term Investments (Tables)	9 Months Ended
	Dec. 31, 2019
Long-term Investments [Abstract]
Schedule of long term investments	Fair Value as at Number December 31, 2019 March 31, FVTPL Share purchase warrants 3,333,333 $ 1,416 $ 19,046 1,000,000 590 5,970 2,006 25,016 Available-for-sale Common shares 3,333,333 51,327 74,830 1,000,000 15,398 22,449 66,725 97,279 Total investment: $ 68,731 $ 122,295

Equipment (Tables)

Equipment (Tables)	9 Months Ended
	Dec. 31, 2019
Property, Plant and Equipment [Abstract]
Schedule of property, plant and equipment	Machinery Total Cost Balance at December 31 & March 31, 2019 $ 232,620 $ 232,620 Accumulated Depreciation Balance at December 31 & March 31, 2019 $ 161,060 $ 161,060 Carrying amounts As at December 31 & March 31, 2019 $ 71,560 $ 71,560

Mineral Property Interest (Tabl

Mineral Property Interest (Tables)	9 Months Ended
	Dec. 31, 2019
Mineral Property Interest [Abstract]
Schedule of acquisition mineral property interest	Mansounia Property, West Africa Acquisition of mineral property interest Cash payment $ 150,000 Issuance of 6,514,350 common shares 781,722 Balance, December 31 & March 31, 2019 $ 931,722

Common Stock (Tables)

Common Stock (Tables)	9 Months Ended
	Dec. 31, 2019
Equity [Abstract]
Schedule of historical information about the Company's warrants	Number of Warrants Weighted Average Exercise Price ($) Weighted Average Life Remaining (Years) Balance, March 31, 2019 117,543,750 0.05 0.98 Warrants issued 1,111,110 0.135 4.6 Warrants exercised (50,000 ) 0.05 Balance, December 31, 2019 118,604,860 0.05 1.02
Schedule of warrants were outstanding and exercisable	Number of Warrants Exercise Price Expiry Date 87,543,750 $ 0.05 February 27, 2020 29,950,000 $ 0.05 April 24, 2023 1,111,110 $ 0.135 August 16, 2024 118,604,860
Schedule of incentive stock options	Number of options Weighted Average Exercise Price ($) Weighted Average Life Remaining (Years) Balance, March 31, 2019 2,150,000 0.23 2.80 Expired (650,000 ) 0.15 Balance, December 31, 2019 1,500,000 0.27 3.10
Schedule of stock options were outstanding and exercisable	Number of Options Exercise Price Weighted Average Remaining Life in Years Expiry Date 1,500,000 $ 0.27 3.1 February 15, 2023

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Dec. 31, 2019
Fair Value Disclosures [Abstract]
Schedule of fair value of assets	Level 1 Level 2 Level 3 Total Cash $ 46,206 $ - $ - $ 46,206 Long-term investment – Shares 66,725 - - 66,725 Long-term investment – Warrants - - 2,006 2,006 Total $ 112,931 $ - $ 2,006 $ 114,937 Level 1 Level 2 Level 3 Total Cash $ 9,792 $ - $ - $ 9,792 Long-term investment – Shares 97,279 - - 97,279 Long-term investment – Warrants - - 25,016 25,016 Total $ 107,071 $ - $ 25,016 $ 132,087

Convertible Debenture (Tables)

Convertible Debenture (Tables)	9 Months Ended
	Dec. 31, 2019
Convertible Debenture Tables Abstract
Schedule of convertible debt and associated financial instruments based on their relative fair values	Proceeds Allocation Debt $ 23,656 Conversion feature 46,638 Warrants 50,867 Shares 13,839 Total proceeds $ 135,000
Schedule of carrying value of the convertible notes	December 31, 2019 Convertible debenture – beginning of the period $ - Debt proceeds received 23,656 Finance cost - accretion 72,950 Carrying value – end of the period $ 96,606

Related Party Transactions (Tab

Related Party Transactions (Tables)	9 Months Ended
	Dec. 31, 2019
Related Party Transactions [Abstract]
Schedule of expenses with related parties	Nine Months Ended 2019 2018 Compensation – CEO $ 40,500 $ 20,705 Compensation – Former CEO - 47,660 Compensation – CFO 21,591 21,805 Compensation – Former Officer - 12,262 $ 62,091 $ 102,432 December 31, March 31, Accounts payable and accrued liabilities $ 119,476 $ 93,104 Due to shareholder (Note 9) 390,164 329,346

Geographical Area Information (

Geographical Area Information (Tables)	9 Months Ended
	Dec. 31, 2019
Segments, Geographical Areas [Abstract]
Schedule of assets and liabilities by geographical area	Canada Africa Total December 31, 2019: Current assets $ 56,071 $ 1,302 $ 57,373 Long term investments 68,731 - 68,731 Equipment - 71,560 71,560 Mineral property interest - 931,722 931,722 Total assets $ 124,802 $ 1,004,584 $ 1,129,386 Total liabilities $ 669,899 $ 94,945 $ 764,844 March 31, 2019: Current assets $ 13,367 $ 1,592 $ 14,959 Long term investments 122,295 - 122,295 Equipment - 71,560 71,560 Mineral property interest - 931,722 931,722 Total assets $ 135,662 $ 1,004,874 $ 1,140,536 Total liabilities $ 509,401 $ 48,953 $ 558,354

Basis of Presentation (Details)

Basis of Presentation (Details) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Mar. 31, 2019
Basis of Presentation (Textual)
Net loss	$ (115,386)	$ (201,105)	$ (300,930)	$ (324,627)
Cumulative losses	$ (22,770,458)		$ (22,770,458)		$ (22,469,528)

Long Term Investments (Details)

Long Term Investments (Details) - USD ($)	9 Months Ended	12 Months Ended
	Dec. 31, 2019	Mar. 31, 2019
FVTPL
Proceeds from share purchase warrants	$ 2,006	$ 25,016
Available-for-sale
Proceeds from common shares	66,725	97,279
Total investment	$ 68,731	122,295
Warrant [Member]
FVTPL
Share purchase warrants	3,333,333
Proceeds from share purchase warrants	$ 1,416	19,046
Warrant One [Member]
FVTPL
Share purchase warrants	1,000,000
Proceeds from share purchase warrants	$ 590	5,970
Common Stock [Member]
Available-for-sale
Common shares	3,333,333
Proceeds from common shares	$ 51,327	74,830
Common Stock One [Member]
Available-for-sale
Common shares	1,000,000
Proceeds from common shares	$ 15,398	$ 22,449

Long Term Investments (Details

Long Term Investments (Details Textual)	Apr. 24, 2018USD ($)	Apr. 16, 2018USD ($)shares	Apr. 16, 2018CAD ($)$ / sharesshares	Aug. 16, 2019$ / sharesshares	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)	Dec. 31, 2019$ / shares
Long Term Investments (Textual)
Proceeds from issuance of private placement								$ 30,484
Fair value of common stock							66,725
Fair value of warrants							2,006
Unrealized loss on warrant							23,010
Unrealized gain on common stock					$ (1,283)	$ 70,373	$ 30,554	$ 14,527
Warrant [Member]
Long Term Investments (Textual)
Issuance of common stock | shares				1,111,110
Share price (in dollars per share) | $ / shares				$ 0.20
Proceeds from issuance of private placement	$ 1,500,000
Valuation method	Black-Scholes option pricing model
Risk free interest rate	2.73%
Volatility	204.30%
Annual rate of dividend	0.00%
Expected life (in years)	5 years
Warrant [Member] | Black-Scholes option pricing model [Member]
Long Term Investments (Textual)
Valuation method							Black-Scholes option pricing model
Risk free interest rate							1.67%
Annual rate of dividend							0.00%
Expected life (in years)							2 months 30 days
Warrant [Member] | Black-Scholes option pricing model [Member] | Minimum [Member]
Long Term Investments (Textual)
Volatility							86.01%
Warrant [Member] | Black-Scholes option pricing model [Member] | Maximum [Member]
Long Term Investments (Textual)
Volatility							88.73%
Ashanti Sankofa Inc [Member] | Private Placement [Member]
Long Term Investments (Textual)
Issuance of common stock | shares		1,000,000	1,000,000
Proceeds from issuance of private placement		$ 23,850
Fair value of common stock		13,420
Fair value of warrants		$ 10,430
Ashanti Sankofa Inc [Member] | Private Placement [Member] | Canada [Member]
Long Term Investments (Textual)
Share price (in dollars per share) | $ / shares			$ 0.03						$ 0.05
Proceeds from issuance of private placement			$ 30,000

Equipment (Details)

Equipment (Details) - USD ($)	Dec. 31, 2019	Mar. 31, 2019
Property, Plant and Equipment, Cost	$ 232,620	$ 232,620
Accumulated Depreciation	161,060	161,060
Carrying amounts	71,560	71,560
Machinery [Member]
Property, Plant and Equipment, Cost	232,620	232,620
Accumulated Depreciation	161,060	161,060
Carrying amounts	$ 71,560	$ 71,560

Equipment (Details Textual)

Equipment (Details Textual)	9 Months Ended
	Dec. 31, 2019
Equipment (Textual)
Equipment, description	Machinery in the amount of $71,560 has not been placed into production and is not currently being depreciated.

Mineral Property Interest (Deta

Mineral Property Interest (Details) - USD ($)	9 Months Ended	12 Months Ended
	Dec. 31, 2019	Mar. 31, 2019
Acquisition of mineral property interest
Cash payment	$ 150,000	$ 150,000
Issuance of 6,514,350 common shares	781,722	781,722
Mineral property interest	$ 931,722	$ 931,722

Mineral Property Interest (De_2

Mineral Property Interest (Details Textual)	1 Months Ended	9 Months Ended		12 Months Ended
	Jul. 24, 2014USD ($)shares	Dec. 31, 2019USD ($)shares	Dec. 31, 2018USD ($)	Mar. 31, 2019USD ($)	Jul. 24, 2014$ / shares
Mineral Property Interest (Textual)
Cash paid		$ 150,000		$ 150,000
Shares Issued | shares		6,514,350
Mineral property expenses		$ 47,574	$ 118,004
Exercised and acquired beneficial interest, description		The Company exercised that right and acquired a 78% beneficial interest in the Property.
Exploitation permit, description		Company’s intention to obtain an exploitation permit to allow the Company the right to mine and dispose of minerals for 15 years, with a possible 5-year extension.
Acquisition [Member]
Mineral Property Interest (Textual)
Cash paid	$ 140,000
Independent valuation of property	$ 10,000
Beneficial interest, percentage	78.00%
BGL [Member]
Mineral Property Interest (Textual)
Cash paid	$ 100,000
Shares Issued, percentage	71.43%	71.43%
EML [Member]
Mineral Property Interest (Textual)
Cash paid	$ 40,000
Shares Issued, percentage	28.57%	28.57%
BGL and EML [Member]
Mineral Property Interest (Textual)
Shares Issued | shares	6,514,350
Mineral property interest	$ 781,722
Deemed price per share | $ / shares					$ 0.1765
Deemed value	1,150,000
Weighted average, property amount	$ 1,150,000

Common Stock (Details)

Common Stock (Details)	9 Months Ended
	Dec. 31, 2019$ / sharesshares
Number of Warrants
Begining balance | shares	117,543,750
Warrants issued | shares	1,111,110
Warrants exercised | shares	(50,000)
Ending balance | shares	118,604,860
Weighted Average Exercise Price
Beginning balance | $ / shares	$ 0.05
Warrants issued | $ / shares	0.135
Warrants exercised | $ / shares	0.05
Ending balance | $ / shares	$ 0.05
Weighted Average Life Remaining (Years)
Beginning balance	11 months 23 days
Warrants issued	4 years 7 months 6 days
Ending balance	1 year 7 days

Common Stock (Details 1)

Common Stock (Details 1) - $ / shares	9 Months Ended
	Dec. 31, 2019	Mar. 31, 2019
Number of Warrants	118,604,860	117,543,750
February 27, 2020 [Member]
Number of Warrants	87,543,750
Exercise Price	$ 0.05
Expiry Date	Feb. 27, 2020
April 24, 2023 [Member]
Number of Warrants	29,950,000
Exercise Price	$ 0.05
Expiry Date	Apr. 24, 2023
August 16, 2024 [Member]
Number of Warrants	1,111,110
Exercise Price	$ 0.135
Expiry Date	Aug. 16, 2024

Common Stock (Details 2)

Common Stock (Details 2) - Stock Option [Member]	9 Months Ended
	Dec. 31, 2019$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding beginning | shares	2,150,000
Expired | shares	(650,000)
Outstanding ending | shares	1,500,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Outstanding, beginning | $ / shares	$ 0.23
Expired | $ / shares	0.15
Outstanding, ending | $ / shares	$ 0.27
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term [Roll Forward]
Outstanding beginning	2 years 9 months 18 days
Outstanding ending	3 years 1 month 6 days

Common Stock (Details 3)

Common Stock (Details 3) - February 15, 2023 [Member]	9 Months Ended
	Dec. 31, 2019$ / sharesshares
Number of Options outstanding | shares	1,500,000
Weighted Average Remaining Life in Years	3 years 1 month 6 days
Exercise Price | $ / shares	$ 0.27
Expiry Date	Feb. 15, 2023

Common Stock (Details Textual)

Common Stock (Details Textual) - USD ($)	Aug. 07, 2018	Jun. 26, 2018	Apr. 24, 2018	Aug. 16, 2019	Jun. 22, 2013	Dec. 31, 2019	Dec. 31, 2018	Mar. 31, 2019
Common Stock (Textual)
Proceeds from private placement							$ 30,484
Gross proceeds						$ 2,500
Warrants expiration period						1 year 7 days		11 months 23 days
Two convertible debenture holders [Member]
Common Stock (Textual)
Issuance of common shares				300,000
Fair value of the common shares				$ 60,000
Private Placement [Member]
Common Stock (Textual)
Warrants Exercise Price			$ 0.05
Warrants expiration period			5 years
Share Purchase Agreement [Member] | Waratah Capital [Member]
Common Stock (Textual)
Issuance of common shares					60,000,000
Share Purchase Agreement [Member] | Waratah Capital [Member] | Private Placement [Member]
Common Stock (Textual)
Proceeds from private placement			$ 1,500,000					$ 1,500,000
Stock Issued During Period, Shares, Acquisitions			30,000,000
Warrants Exercise Price			$ 0.05
Common Stock [Member]
Common Stock (Textual)
Gross proceeds						$ 1
Issuance of common shares							30,000,000
Warrant [Member]
Common Stock (Textual)
Proceeds from private placement			$ 1,500,000
Stock Issued During Period, Shares, Acquisitions			30,000,000
Share price				$ 0.20
Warrants Exercise Price			$ 0.05
Warrants expiration period			5 years
Valuation method			Black-Scholes option pricing model
Risk free interest rate			2.73%
Volatility			204.30%
Annual rate of dividend			0.00%
Expected life (in years)			5 years
Issuance of common shares				1,111,110
Fair value of the common shares				$ 220,541
Warrant exercised for common shares						50,000
Warrant [Member] | Two convertible debenture holders [Member]
Common Stock (Textual)
Warrants Exercise Price				$ 0.135
Risk free interest rate				1.57%
Volatility				231.60%
Annual rate of dividend				0.00%
Expected life (in years)				5 years
Stock Option [Member]
Common Stock (Textual)
Share price		$ 0.163
Stock Option [Member] | Common Stock [Member]
Common Stock (Textual)
Stock Issued During Period, Shares, Acquisitions		245,400
Option Exercised	650,000	4,000,000
Proceeds from stock option exercised		$ 40,000
Exercise price		$ 0.01
Issuance of common shares		3,754,600

Fair Value of Financial Instr_3

Fair Value of Financial Instruments (Details) - USD ($)	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2018	Mar. 31, 2018
Cash	$ 46,206	$ 9,792	$ 8,182	$ 28,481
Long-term investment - Shares	66,725	97,279
Long-term investment - Warrants	2,006	25,016
Total	114,937	132,087
Level 1 [Member]
Cash	46,206	9,792
Long-term investment - Shares	66,725	97,279
Long-term investment - Warrants
Total	112,931	107,071
Level 2 [Member]
Cash
Long-term investment - Shares
Long-term investment - Warrants
Total
Level 3 [Member]
Cash
Long-term investment - Shares
Long-term investment - Warrants	2,006	25,016
Total	$ 2,006	$ 25,016

Due to Shareholder (Details)

Due to Shareholder (Details) - USD ($)	9 Months Ended
	Dec. 31, 2019	Mar. 31, 2019
Due to Shareholder (Textual)
Due to shareholder	$ 390,164	$ 329,346
Waratah Capital [Member]
Due to Shareholder (Textual)
Advance from related party	60,820
Due to shareholder	$ 390,164	$ 329,346

Convertible Debenture (Details)

Convertible Debenture (Details)	9 Months Ended
	Dec. 31, 2019USD ($)
Convertible Debenture
Debt	$ 23,656
Conversion feature	46,638
Warrants	50,867
Shares	13,839
Total proceeds	$ 135,000

Convertible Debenture (Details

Convertible Debenture (Details 1) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Convertible Debenture
Convertible debenture - beginning of the period
Debt proceeds received			23,656
Finance cost - accretion	$ 56,162		72,950
Carrying value - end of the period	$ 96,606		$ 96,606

Convertible Debenture (Detail_2

Convertible Debenture (Details Textual) - USD ($)	Apr. 24, 2018	Aug. 16, 2019	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Mar. 31, 2019
Debt instrument term			1 year 7 days		1 year 7 days		11 months 23 days
Accretion for the notes			$ 56,162		$ 72,950
Interest expense					$ 2,516
Two investors [Member]
Issuance of common shares		300,000
Fair value of the common shares		$ 60,000
Warrants [Member]
Issuance of common shares		1,111,110
Fair value of the common shares		$ 220,541
Debt instrument term	5 years
Risk free interest rate	2.73%
Volatility	204.30%
Annual rate of dividend	0.00%
Expected life (in years)	5 years
Two warrant [Member]
Purchase of warrants		1,111,110
Exercise price		$ 0.135
Debt instrument term		5 years
Convertible Promissory Notes [Member]
Aggregate principal amount		$ 150,000
Original issue discount		15,000
Legal fees		$ 10,000
Accrues interest rate		5.00%
Conversion price, description		i) $0.09 (fixed conversion price); or ii) 50% multiplied by the lowest closing bid price of the Common Stock during the 25 consecutive trading day period immediately preceding the date of the respective conversion (alternative conversion price) into common shares of the Company after 180 days and prior to May 16, 2020.
Discount factor rate		66.00%
Risk free interest rate		1.61%
Volatility		100.01%
Annual rate of dividend		0.00%
Expected life (in years)		9 months
Conversion feature, value		$ 202,208
Promissory debt, value		$ 102,567

Commitments (Details)

Commitments (Details) - USD ($)	Apr. 24, 2018	Jun. 22, 2013	Dec. 31, 2019	Dec. 31, 2018	Mar. 31, 2019
Warrants issued			1,111,110
Proceeds from private placement				$ 30,484
Share Purchase Agreement [Member] | Waratah [Member]
Percentage of shares outstanding held by related party		100.00%
Share Purchase Agreement [Member] | Waratah Capital [Member]
Issuance of common stock		60,000,000
Warrants issued		60,000,000
Share price		$ 0.05
Warrant term		5 years
Share Purchase Agreement [Member] | Waratah Capital [Member] | Private Placement [Member]
Proceeds from private placement	$ 1,500,000				$ 1,500,000

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	9 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Compensation	$ 62,091	$ 102,432
CEO [Member]
Compensation	40,500	20,705
Former CEO [Member]
Compensation		47,660
CFO [Member]
Compensation	21,591	21,805
Former Officer [Member]
Compensation		$ 12,262

Related Party Transactions (D_2

Related Party Transactions (Details 1) - USD ($)	Dec. 31, 2019	Mar. 31, 2019
Related Party Transactions [Abstract]
Accounts payable and accrued liabilities	$ 119,476	$ 93,104
Due to shareholder (Note 9)	$ 390,164	$ 329,346

Geographical Area Information_2

Geographical Area Information (Details) - USD ($)	Dec. 31, 2019	Mar. 31, 2019
Current assets	$ 57,373	$ 14,959
Long term investments	68,731	122,295
Equipment	71,560	71,560
Mineral property interest	931,722	931,722
Total assets	1,129,386	1,140,536
Total liabilities	764,844	558,354
Canada [Member]
Current assets	56,071	13,367
Long term investments	68,731	122,295
Equipment
Mineral property interest
Total assets	124,802	135,662
Total liabilities	669,899	509,401
Africa [Member]
Current assets	1,302	1,592
Long term investments
Equipment	71,560	71,560
Mineral property interest	931,722	931,722
Total assets	1,004,584	1,004,874
Total liabilities	$ 94,945	$ 48,953